Nonpulmonary medical complications in the intermediate and long-term survivor.
This article deals with the nonpulmonary, non-infectious complications in intermediate and long-term survivors of lung transplantation. Although they are an infrequent cause of mortality, these disorders can cause significant morbidity in this population. Diseases associated with the gamut of medications used post-transplant are specifically discussed, as are diseases caused by the direct immunosuppressive action of some of these drugs. General care of transplant patients also entails attention to their underlying diseases, and to routine medical considerations common to all patients.
Maurer
J R
JR
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, Ohio, USA.
Tewari
S
S
D001847:Bone Diseases / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology; D005767:Gastrointestinal Diseases / Q000209:etiology; D006402:Hematologic Diseases / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007674:Kidney Diseases / Q000209:etiology; D016040:Lung Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000209:etiology; D008659:Metabolic Diseases / Q000209:etiology; D009422:Nervous System Diseases / Q000209:etiology; D016019:Survival Analysis
D007166:Immunosuppressive Agents